TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Insmed Inc (INSM)

Healthcare Biotechnology
98.50 $
-0.2% vs. previous close
Closing price · As of: 3. Aug 2026

Insmed Inc (INSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 2,076 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet INSM
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
1,439 1,325 1,330 1,159 1,810 2,053 2,025 1,803 2,480 2,361 2,265 2,076
1,052 927 929 759 1,418 1,650 1,622 1,403 2,082 1,932 1,794 1,613
613 487 482 596 1,247 461 555 403 1,284 335 510 582
918 786 780 596 1,247 1,468 1,434 1,199 1,857 1,680 1,430 1,224
31 36 41 37 40 42 52 48 55 65 141 179
77 78 83 83 90 98 99 101 108 121 132 133
62 – – – – – – – – – – –
136 136 136 136 136 136 136 136 136 136 136 136
66 65 64 62 61 60 59 57 56 85 98 96
1,595 1,614 1,662 1,624 1,771 1,570 1,740 1,704 1,230 1,415 1,526 1,371
204 197 226 421 524 259 298 239 312 417 469 361
6.6 8.9 14 235 237 14 16 10 11 12 19 14
56 65 65 44 51 65 73 58 74 80 80 73
1,140 1,148 1,155 939 947 955 1,103 1,105 539 540 541 542
-156 -289 -332 -465 39 483 285 99 1,250 946 739 705
-3,101 -3,260 -3,446 -3,603 -3,904 -4,124 -4,360 -4,617 -4,938 -5,308 -5,637 -5,800
138 143 145 148 155 174 179 181 189 211 214 215

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?